Vorinostat, Isotretinoin and Temozolomide in Adults With Recurrent Glioblastoma Multiforme (GBM)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Temozolomide
Related studies linked through entity extraction aliases.
Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Gliadel Wafer, Temozolomide and Radiation Therapy for Newly Diagnosed GBM
- Status
- TERMINATED
- Phase
- PHASE2
Temozolomide in Treating Patients With Primary Brain Tumors or Metastatic Brain Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Radiation Therapy and Temozolomide Followed by Temozolomide Plus Sorafenib for Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE2
Bortezomib and Temozolomide in Treating Patients With Brain Tumors or Other Solid Tumors That Have Not Responded to Treatment
- Status
- COMPLETED
- Phase
- PHASE1
Phase II Study Incorporating Pegylated Interferon In the Treatment For Children With High-Risk Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Temozolomide, Thalidomide, and Lomustine (TTL) in Melanoma Patients
- Status
- COMPLETED
- Phase
- PHASE1
A Phase I Study of ABT-888 in Combination With Temozolomide in Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE1
Study of Bevacizumab Plus Temodar and Tarceva in Patients With Glioblastoma or Gliosarcoma
- Status
- COMPLETED
- Phase
- PHASE2
Temozolomide vs. Temozolomide and Thalidomide Treatment in Recurrent Glioblastoma
- Status
- UNKNOWN
- Phase
- PHASE2
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
- Status
- COMPLETED
- Phase
- PHASE2
Enzastaurin and Temozolomide in Treating Patients With Primary Gliomas
- Status
- UNKNOWN
- Phase
- PHASE1
VNP40101M and Temozolomide in Treating Patients With Progressive or Relapsed Malignant Glioma
- Status
- TERMINATED
- Phase
- PHASE1
DepoCyt Plus Temozolomide in Patients With Neoplastic Meningitis
- Status
- TERMINATED
- Phase
- PHASE1
Temozolomide and Radiation Therapy in Treating Young Patients With Pontine Glioma
- Status
- UNKNOWN
- Phase
- PHASE2
Bortezomib and Temozolomide in Treating Patients With Advanced Refractory Solid Tumors or Melanoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Biochemotherapy With Temozolomide for Metastatic Melanoma
- Status
- TERMINATED
- Phase
- PHASE2
6-TG, Capecitabine and Celecoxib Plus TMZ or CCNU for Anaplastic Glioma Patients
- Status
- COMPLETED
- Phase
- PHASE2
Temozolomide in Treating Patients With Recurrent Glioblastoma Multiforme or Other Malignant Glioma
- Status
- COMPLETED
- Phase
- PHASE2